HDRN Canada is pleased to announce the appointment of Josette-Renée Landry and Pamela Valentine to its Board of Directors.
Informed by their unique experiences, they bring valuable expertise and perspectives to provide effective governance and guide HDRN Canada in achieving its strategic goals.
“We are so fortunate to welcome two new Board members with such depth of expertise and experience,” said Kim McGrail, Scientific Director and CEO of HDRN Canada. “Dr. Valentine’s and Dr. Landry’s perspectives from the hospital sector, funding agencies, and specific disease interests will be invaluable as we continue with our mission to support multi-regional research.”
Josette is the CEO of l’Institut du Savoir Montfort and Vice-President, Research and Education at Hôpital Montfort. She is also the founder of Streamline Genomics and Adjunct Professor in the Faculty of Medicine at Université de Montréal. She was previously Vice President, Business Development for Mitacs, where she helped facilitate partnerships between university researchers and industry.
Josette received her Ph.D. in Genetics from the University of British Columbia, followed by postdoctoral training at the University of Cambridge. She holds an MBA from HEC Montréal and has served on a diverse roster of academic, industry, and research committees.
Dr. Pamela Valentine joined the Multiple Sclerosis Society of Canada in 2018 with the drive and passion to lead the team of volunteers and staff in their work to accelerate research for better treatments and care, advocate for policy and system changes, and work towards improving lives for people living with MS.
Pam recently led the development of a new strategic plan – Discover. Innovate. Act. -- in collaboration with hundreds of stakeholders from across the country, including people living with and affected by MS, members of the scientific community, volunteers, staff, and donors. A trained neuroscientist, Pam came to the MS Society from Alberta Innovates where she spent over a decade and a half leading innovation and change. Her leadership at Alberta Innovates included significantly growing the health research portfolio and strengthening integration of research and health systems to maximize impact for patients and providers.